Michael P LaValley
Overview
Explore the profile of Michael P LaValley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
3020
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lui J, Sangani R, Gillmeyer K, Vakhshoorzadeh J, Trojanowski M, Bujor A, et al.
Cardiovasc Drugs Ther
. 2023 Jan;
38(3):657.
PMID: 36662449
No abstract available.
12.
Lui J, Sangani R, Gillmeyer K, Vakhshoorzadeh J, Trojanowski M, Bujor A, et al.
Cardiovasc Drugs Ther
. 2023 Jan;
38(3):651-656.
PMID: 36607535
Purpose: Although classified as group 1 pulmonary arterial hypertension (PAH), patients with systemic sclerosis-related pulmonary hypertension (SSc-PH) experience poorer clinical response to PAH therapy and increased mortality compared to those...
13.
Corrigan P, Felson D, Lewis C, Neogi T, LaValley M, Gross K, et al.
Arthritis Care Res (Hoboken)
. 2022 Oct;
75(8):1735-1743.
PMID: 36305013
Objective: We aimed to explore the cross-sectional relation of unilateral knee pain severity and temporal asymmetry during walking and to determine relations of temporal asymmetry during walking to 2-year changes...
14.
Sangani R, Lui J, Gillmeyer K, Trojanowski M, Bujor A, LaValley M, et al.
Pulm Circ
. 2022 Oct;
12(4):e12117.
PMID: 36238967
Patients with systemic sclerosis complicated by both pulmonary hypertension (SSc-PH) and interstitial lung disease (SSc-PH-ILD) have poor prognosis compared to those with SSc-PH or SSc-ILD alone. Little is known of...
15.
Liu Q, Chu H, LaValley M, Hunter D, Zhang H, Tao L, et al.
Lancet Rheumatol
. 2022 Sep;
4(2):e125-e134.
PMID: 36177295
Background: Few prognostic prediction models for total knee replacement are available, and the role of radiographic findings in predicting its use remains unclear. We aimed to develop and validate predictive...
16.
Quinn K, Ahlman M, Alessi H, LaValley M, Neogi T, Marko J, et al.
Arthritis Rheumatol
. 2022 Jul;
75(1):98-107.
PMID: 35792044
Objective: To assess whether vascular activity seen on F-fluorodeoxyglucose-positron emission tomography (FDG-PET) scan is associated with angiographic change in large vessel vasculitis (LVV). Methods: Patients with LVV were recruited into...
17.
Lui J, Gillmeyer K, Sangani R, Smyth R, Gopal D, Trojanowski M, et al.
Arthritis Care Res (Hoboken)
. 2022 Jun;
75(7):1462-1468.
PMID: 35678779
Objective: Diagnosis of pulmonary hypertension (PH) in systemic sclerosis (SSc) requires an invasive right heart catheterization (RHC), often based on an elevated estimated pulmonary artery systolic pressure on screening echocardiography....
18.
Zhou T, LaValley M, Nelson K, Cabral H, Massaro J
Stat Med
. 2022 Apr;
41(17):3321-3335.
PMID: 35486817
The Finkelstein and Schoenfeld (FS) test is a popular generalized pairwise comparison approach to analyze prioritized composite endpoints (eg, components are assessed in order of clinical importance). Power and sample...
19.
Felson D, Lacaille D, LaValley M, Aletaha D
Ann Rheum Dis
. 2022 Feb;
82(8):e184.
PMID: 35177411
No abstract available.
20.
Bor J, Kluberg S, LaValley M, Evans D, Hirasen K, Maskew M, et al.
Am J Epidemiol
. 2022 Jan;
191(6):999-1008.
PMID: 35081613
Simplified drug regimens may improve retention in care for persons with chronic diseases. In April 2013, South Africa adopted a once-daily single-pill human immunodeficiency virus (HIV) treatment regimen as the...